Publication:
Optochemogenetics (OCG) allows more precise control of genetic engineering in mice with CreER regulators

No Thumbnail Available

Date

2012

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

American Chemical Society
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Lu, Xin, Sarit S. Agasti, Claudio Vinegoni, Peter Waterman, Ronald A. DePinho, and Ralph Weissleder. 2012. “Optochemogenetics (OCG) Allows More Precise Control of Genetic Engineering in Mice with CreER Regulators.” Bioconjugate Chemistry 23 (9): 1945–51. https://doi.org/10.1021/bc300319c.

Research Data

Abstract

New approaches that allow precise spatiotemporal control of gene expression in model organisms at the single cell level are necessary to better dissect the role of specific genes and cell populations in development, disease, and therapy. Here, we describe a new optochemogenetic switch (OCG switch) to control CreER/loxP-mediated recombination via photoactivatable ("caged") tamoxifen analogues in individual cells in cell culture, organoid culture, and in vivo in adult mice. This approach opens opportunities to more fully exploit existing CreER transgenic mouse strains to achieve more precise temporal- and location-specific regulation of genetic events and gene expression.

Description

Other Available Sources

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories